CorMedix Inc.·4

Jan 27, 9:30 PM ET

Zelnick Kaufman Beth 4

Research Summary

AI-generated summary

Updated

CorMedix (CRMD) CLO Beth Zelnick Kaufman Receives RSU Award

What Happened

  • Beth Zelnick Kaufman, Chief Legal Officer of CorMedix Inc. (CRMD), was granted 72,820 restricted stock units (RSUs) on 2026-01-23 (reported on a Form 4 filed 2026-01-27). The RSUs were reported at $0.00 (award). To cover tax withholding, 8,803 shares were withheld/disposed at $7.27 per share, totaling $63,998. This transaction is an equity award (compensation), not an open-market buy or voluntary sale.

Key Details

  • Transaction date: 2026-01-23; Form 4 filed: 2026-01-27 (appears filed after the typical 2-business-day reporting window)
  • Award (code A): 72,820 RSUs @ $0.00
  • Tax withholding (code F): 8,803 shares withheld @ $7.27 = $63,998
  • Vesting (footnote): 1/4 vests on grant date, then 1/4 on each anniversary for the next three years, subject to continued employment
  • Shares owned after transaction: not specified in the filing
  • Filing includes Exhibit 24.1 (Power of Attorney)

Context

  • RSUs are a form of compensation; because 1/4 vests immediately the recipient receives value up front. The withholding of shares to satisfy taxes (code F) is a routine administrative step and should not be read as a market sell signal. The apparent late filing (filed 1/27 for a 1/23 transaction) may be worth noting for compliance tracking.